Victory Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $439K | Buy |
|
|||||
|
2023
Q3 | $308K | Buy |
|
|||||
|
2023
Q2 | $210K | Sell |
|
|||||
|
2023
Q1 | $221K | Buy |
|
|||||
|
2022
Q4 | $266K | Sell |
|
|||||
|
2022
Q3 | $410K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $8.89M | Buy |
|
|||||
|
2021
Q4 | $13.2M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $16M | Sell |
|
|||||
|
2020
Q4 | $85.7M | Buy |
|
|||||
|
2020
Q3 | $63.6M | Buy |
|
|||||
|
2020
Q2 | $41.5M | Sell |
|
|||||
|
2020
Q1 | $64.1M | Buy |
|
|||||
|
2019
Q4 | $54.6M | Buy |
|
|||||
|
2019
Q3 | $27.4M | Buy |
|
|||||
|
2019
Q2 | $27.8M | Buy |
|